[Human adipose derived stem cells suppress lymphocyte proliferation induced by cellular or nonspecific mitogenic

Lei Cui1, Shuo Yin, Ping Yang

  • 1Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Second Medical University, Shanghai Tissue Engineering Research and Development Center, Shanghai 200011, China.

Zhonghua Yi Xue Za Zhi
|November 1, 2005
PubMed

Insights

Adipose-derived stem cells (ADSC) do not trigger immune responses and can modulate lymphocyte activity in vitro. These findings highlight ADSC

Area of Science:

  • Immunology
  • Stem Cell Biology

Context:

  • Adipose-derived stem cells (ADSC) are being investigated for their therapeutic potential.
  • Understanding the immunomodulatory properties of ADSC is crucial for their clinical application.

Purpose:

  • To investigate the immunological characteristics of ADSC.
  • To evaluate the in vitro immunomodulatory effects of ADSC on lymphocytes.

Summary:

  • ADSC were isolated and analyzed for Human Leukocyte Antigen (HLA) expression.
  • Peripheral blood lymphocytes (PBL) were cultured with ADSC in mixed lymphocyte reactions (MLR).
  • ADSC demonstrated dose-dependent inhibition of lymphocyte proliferation, even after IFN-gamma treatment.

Impact:

  • Undifferentiated ADSC do not induce alloreactive lymphocyte proliferation.
  • ADSC possess immunomodulatory capabilities, suggesting potential for immune tolerance induction.
  • These findings support the use of ADSC in cell-based therapies requiring immune modulation.
Abstract